ATNF Logo

180 Life Sciences Corp. (ATNF) 

NASDAQ
Market Cap
$1.44M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
373 of 809
Rank in Industry
227 of 445

Largest Insider Buys in Sector

ATNF Stock Price History Chart

ATNF Stock Performance

About 180 Life Sciences Corp.

1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.

Insider Activity of 180 Life Sciences Corp.

Over the last 12 months, insiders at 180 Life Sciences Corp. have bought $4,700 and sold $4,700 worth of 180 Life Sciences Corp. stock.

On average, over the past 5 years, insiders at 180 Life Sciences Corp. have bought $101,930 and sold $71,985 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Woody James N. (Chief Executive Officer) — $4,700.

The last purchase of 25,000 shares for transaction amount of $4,700 was made by Woody James N. (Chief Executive Officer) on 2023‑12‑15.

List of Insider Buy and Sell Transactions, 180 Life Sciences Corp.

2023-12-15SaleFeldmann Marcdirector
25,000
0.3408%
$0.19$4,700-17.09%
2023-12-15PurchaseWoody James N.Chief Executive Officer
25,000
0.3408%
$0.19$4,700-17.09%
2023-06-01PurchaseSTEINMAN LAWRENCEdirector
18,000
0.4949%
$1.23$22,068-75.14%
2023-05-31PurchaseMcGovern Jr. Donald A.director
10,000
0.2685%
$1.15$11,470-73.87%
2023-05-19PurchaseMcGovern Jr. Donald A.director
5,000
0.1238%
$1.16$5,800-71.16%
2023-05-18PurchaseWoody James N.Chief Executive Officer
40,000
1.0572%
$1.03$41,200-65.28%
2023-05-18PurchaseMcGovern Jr. Donald A.director
10,000
0.2694%
$1.05$10,500-65.28%
2023-05-18PurchaseMarrone Pamela Gdirector
7,082.02
0.1926%
$1.06$7,507-65.28%
2023-05-18PurchasePamir OzanCFO
5,162.08
0.1338%
$1.01$5,214-65.28%
2021-12-16PurchaseVu Quan AnhCOO / Chief Business Officer
8,000
23.6901%
$3.98$31,840-69.82%
2021-12-10PurchasePamir OzanInterim CFO
3,800
10.646%
$3.87$14,706-69.53%
2021-12-10PurchaseVu Quan AnhCOO / Chief Business Officer
4,500
12.7049%
$3.90$17,550-69.53%
2021-12-10PurchaseMarrone Pamela Gdirector
1,000
2.9681%
$4.10$4,100-69.53%
2021-12-09PurchaseSTEINMAN LAWRENCEdirector
5,000
15.7263%
$4.27$21,350-68.88%
2021-12-09PurchaseWoody James N.Chief Executive Officer
12,500
39.3157%
$4.27$53,375-68.88%
2021-12-09PurchaseMcGovern Jr. Donald A.director
25,000
76.0533%
$4.13$103,250-68.88%
2021-12-09PurchaseDeLuca Teresadirector
12,500
36.6824%
$3.98$49,800-68.88%
2020-12-17SaleKRAUSS MARLENE10 percent owner
16,506
65.4229%
$2.48$40,880+109.89%
2020-12-15SaleKRAUSS MARLENE10 percent owner
17,877
81.3034%
$2.40$42,905+148.54%
2020-12-14SaleKRAUSS MARLENE10 percent owner
10,000
45.4755%
$2.45$24,500+143.44%

Insider Historical Profitability

<0.0001%
Feldmann Marcdirector
115497
1.1369%
$1.5301
Woody James N.Chief Executive Officer
66888
0.6584%
$1.5340+12.83%
KRAUSS MARLENE10 percent owner
2006858
19.7549%
$1.5306
OXFORD ASSET MANAGEMENT LLP10 percent owner
832185
8.1918%
$1.5308
STEINMAN LAWRENCEdirector
48129
0.4738%
$1.5320<0.0001%
McGovern Jr. Donald A.director
30099
0.2963%
$1.5340<0.0001%
Vu Quan AnhCOO / Chief Business Officer
20500
0.2018%
$1.5320
Marrone Pamela Gdirector
12469
0.1227%
$1.5320<0.0001%
Pamir OzanCFO
8983
0.0884%
$1.5320<0.0001%
DeLuca Teresadirector
5000
0.0492%
$1.5310

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
No records found…